Neuro-COVID-19 is more than anosmia: clinical presentation,... : Current Opinion in
Neurology Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics …

The ongoing pandemic Coronavirus Disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern in terms of …

The mechanisms of olfactory dysfunction in COVID-19 are still unclear. In this review, we
examine potential mechanisms that may explain why the sense of smell is lost or altered …

The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …

Background The SARS‐CoV‐2 virus continues to spread rapidly across the globe afflicting
many with Coronavirus Disease 2019 (COVID‐19). As the infection rates rise, a growing …

Abstract Background Coronavirus disease 2019 (COVID-19) is primarily an acute respiratory
tract infection. Distinctively, a substantial proportion of COVID-19 patients develop olfactory …

COVID-19 is hopefully approaching its end in many countries as herd immunity develops
and weaker strains of SARS-CoV-2 dominate. However, a new concern occurs over the long …

Recent reports suggest an association between COVID-19 and altered olfactory function.
Here we analyze bulk and single cell RNA-Seq datasets to identify cell types in the olfactory …

The new coronavirus disease COVID-19 was identified in December 2019. It subsequently
spread across the world with over 125 M reported cases and 2.75 M deaths in 190 countries …

SARS-CoV-2 infects less than 1% of cells in the human body, yet it can cause severe
damage in a variety of organs. Thus, deciphering the non-cell-autonomous effects of SARS …